Drug Shortage Report for PMS-TADALAFIL
Report ID | 64838 |
Drug Identification Number | 02409445 |
Brand name | PMS-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-10-17 |
Estimated end date | 2020-01-03 |
Actual end date | 2020-06-02 |
Shortage status | Resolved |
Updated date | 2020-06-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-19 | English | Compare |
v2 | 2018-10-19 | French | Compare |
v3 | 2019-01-16 | English | Compare |
v4 | 2019-01-16 | French | Compare |
v5 | 2019-01-16 | English | Compare |
v6 | 2019-01-16 | French | Compare |
v7 | 2019-06-28 | English | Compare |
v8 | 2019-06-28 | French | Compare |
v9 | 2019-11-15 | English | Compare |
v10 | 2019-11-15 | French | Compare |
v11 | 2020-06-03 | English | Compare |
v12 | 2020-06-03 | French | Compare |
Showing 1 to 12 of 12